Privia Health (PRVA) Long-Term Deferred Tax (2020 - 2025)

Privia Health's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $2.3 million for Q4 2025.

• On a quarterly basis, Long-Term Deferred Tax fell 91.38% year-over-year to $2.3 million in Q4 2025; TTM through Dec 2025 was $2.3 million, a 91.38% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 91.38% from the prior year.
• Long-Term Deferred Tax slipped to $2.3 million in Q4 2025 per PRVA's latest filing, from $17.0 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $40.4 million in Q4 2022 and bottomed at $2.3 million in Q4 2025.
• The 5-year median for Long-Term Deferred Tax is $26.9 million (2022), against an average of $26.7 million.
• Across the five-year window, Long-Term Deferred Tax surged 816.22% in 2022 and tumbled 91.38% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $33.4 million in 2021, then grew by 20.99% to $40.4 million in 2022, then dropped by 12.8% to $35.2 million in 2023, then declined by 25.05% to $26.4 million in 2024, then sank by 91.38% to $2.3 million in 2025.
• Per Business Quant, the three latest PRVA Long-Term Deferred Tax figures stand at $2.3 million (Q4 2025), $17.0 million (Q3 2025), and $23.7 million (Q2 2025).